153 related articles for article (PubMed ID: 35668046)
1. Successful conversion surgery after FOLFIRINOX therapy in a patient with advanced pancreatic acinar cell carcinoma with a solitary peritoneal dissemination: A case report.
Uemura S; Maeda H; Tanioka N; Yamaguchi S; Munekage M; Kitagawa H; Namikawa T; Yamamoto S; Kohsaki T; Iguchi M; Uchida K; Hanazaki K
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1648. PubMed ID: 35668046
[TBL] [Abstract][Full Text] [Related]
2. Painful lower limb nodules as first symptom of resectable pancreatic acinar cell cancer: a case report.
Haenen SM; Tol JAMG; van Steen SCJ; Busch OR; Sarasqueta AF; Roshani S; Wolkerstorfer A; van der Linden MMD; Wilmink JW; Post HC; Besselink MG
J Med Case Rep; 2022 Oct; 16(1):356. PubMed ID: 36195885
[TBL] [Abstract][Full Text] [Related]
3. A case of pathologically complete response after preoperative chemotherapy in a pancreatic acinar cell carcinoma patient with portal vein tumor thrombosis.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Takayama Y; Shimizu K; Tokushige K; Egawa H; Yamamoto M
Clin J Gastroenterol; 2022 Jun; 15(3):642-648. PubMed ID: 35013933
[TBL] [Abstract][Full Text] [Related]
4. Conversion Surgery for Metastatic Pancreatic Mucinous Carcinoma Responsive to Systemic Chemotherapy with Modified FOLFIRINOX: A Case Report.
Yokoyama T; Makino H; Hirakata A; Ueda J; Takata H; Okusa M; Kawashima M; Tsujino T; Hosone M; Matsushita A; Nakamura Y; Yoshida H
J Nippon Med Sch; 2019 Dec; 86(5):284-290. PubMed ID: 31105119
[TBL] [Abstract][Full Text] [Related]
5. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
[TBL] [Abstract][Full Text] [Related]
6. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX.
Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H
Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
8. CT evaluation after neoadjuvant FOLFIRINOX chemotherapy for borderline and locally advanced pancreatic adenocarcinoma.
Wagner M; Antunes C; Pietrasz D; Cassinotto C; Zappa M; Sa Cunha A; Lucidarme O; Bachet JB
Eur Radiol; 2017 Jul; 27(7):3104-3116. PubMed ID: 27896469
[TBL] [Abstract][Full Text] [Related]
9. Successful chemotherapy with modified FOLFIRINOX for pancreatic acinar cell carcinoma.
Hashimoto M; Hikichi T; Suzuki T; Tai M; Ichii O; Matsuhashi N; Kita E; Takahashi S; Okubo Y; Hakozaki H; Ejiri Y; Ohira H
Clin J Gastroenterol; 2017 Dec; 10(6):564-569. PubMed ID: 29052123
[TBL] [Abstract][Full Text] [Related]
10. [Resectable Pancreatic Cancer Successfully Treated with Neoadjuvant Chemotherapy Regimen Change to Modified FOLFIRINOX-A Case Report].
Terao H; Maruyama T; Aono T; Suzuki S; Kaneko K; Sato T; Okada T; Muto I; Hasegawa M; Muneoka Y; Tajima Y; Ichikawa H; Shimada Y; Sakata J; Wakai T
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1569-1571. PubMed ID: 38303344
[TBL] [Abstract][Full Text] [Related]
11. Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: A case report.
Li M; Mou Y; Hou S; Cao D; Li A
Medicine (Baltimore); 2018 Nov; 97(45):e13113. PubMed ID: 30407325
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment.
van Roessel S; van Veldhuisen E; Klompmaker S; Janssen QP; Abu Hilal M; Alseidi A; Balduzzi A; Balzano G; Bassi C; Berrevoet F; Bonds M; Busch OR; Butturini G; Del Chiaro M; Conlon KC; Falconi M; Frigerio I; Fusai GK; Gagnière J; Griffin O; Hackert T; Halimi A; Klaiber U; Labori KJ; Malleo G; Marino MV; Mortensen MB; Nikov A; Lesurtel M; Keck T; Kleeff J; Pandé R; Pfeiffer P; Pietrasz D; Roberts KJ; Sa Cunha A; Salvia R; Strobel O; Tarvainen T; Bossuyt PM; van Laarhoven HWM; Wilmink JW; Groot Koerkamp B; Besselink MG;
JAMA Oncol; 2020 Nov; 6(11):1733-1740. PubMed ID: 32910170
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.
Callata-Carhuapoma HR; Pato Cour E; Garcia-Paredes B; Fernandez RM; Mendoza Fernandez ML; Fernandez AM; De La Rosa CA; Sotelo Lezama MJ; Cabezas-Camarero S; Sastre Varela J
Pancreatology; 2015; 15(4):440-4. PubMed ID: 25959244
[TBL] [Abstract][Full Text] [Related]
14. [A case of liver metastasis of mixed acinar-endocrine carcinoma treated with various loco-regional cancer therapies].
Nishii T; Amano R; Nakao S; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2126-8. PubMed ID: 19106545
[TBL] [Abstract][Full Text] [Related]
15. Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.
Distler M; Rückert F; Dittert DD; Stroszczynski C; Dobrowolski F; Kersting S; Grützmann R
World J Surg Oncol; 2009 Feb; 7():22. PubMed ID: 19239719
[TBL] [Abstract][Full Text] [Related]
16. Effective intra-arterial chemotherapy for acinar cell carcinoma of the pancreas.
Ukei T; Okagawa K; Uemura Y; Miyauchi K; Kaneko T; Mizunoya S; Monden M
Dig Surg; 1999; 16(1):76-9. PubMed ID: 9949272
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients with Borderline Resectable Pancreatic Cancer Treated with Combination Chemotherapy.
Templeton S; Moser M; Wall C; Shaw J; Chalchal H; Luo Y; Zaidi A; Ahmed S
J Gastrointest Cancer; 2021 Jun; 52(2):529-535. PubMed ID: 32440849
[TBL] [Abstract][Full Text] [Related]
18. A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX.
Yamada S; Motegi H; Kurihara Y; Shimbo T; Kikuchi I; Wakabayashi T; Sato T
Surg Case Rep; 2023 Aug; 9(1):147. PubMed ID: 37610633
[TBL] [Abstract][Full Text] [Related]
19. [A Difficult Diagnostic Case of Pancreatic Acinar Cell Carcinoma].
Matsui H; Sakamoto K; Matsukuma S; Tokumitsu Y; Tokuhisa Y; Kanekiyo S; Tomochika S; Iida M; Suzuki N; Takeda S; Yoshino S; Hazama S; Ueno T; Nagano H
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1235-1237. PubMed ID: 29394592
[TBL] [Abstract][Full Text] [Related]
20. Borderline or locally advanced pancreatic adenocarcinoma: A single center experience on the FOLFIRINOX induction regimen.
Garnier J; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Giovannini M; Poizat F; Delpero JR; Turrini O
Eur J Surg Oncol; 2020 Aug; 46(8):1510-1515. PubMed ID: 32146053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
